Author： Hsu Jerry Y. Wakelee Heather A.
Publisher： Adis International
ISSN： 1173-8804
Source： BioDrugs, Vol.23, Iss.5, 2009-10, pp. : 289-304
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Current Status and Challenges Associated with Targeting mTOR for Cancer Therapy
BioDrugs, Vol. 23, Iss. 2, 2009-06 ,pp. :
Access to resources
Recommend
Cellular Vehicles for Cancer Gene Therapy: Current Status and Future Potential
By Larisa Pereboeva David T. Curiel
BioDrugs, Vol. 18, Iss. 6, 2004-01 ,pp. :
Complications of Anti-Vascular Endothelial Growth Factor Drugs
Current Drug Therapy, Vol. 7, Iss. 2, 2012-06 ,pp. :
Targeting T Cells with Bispecific Antibodies for Cancer Therapy
By Lum Lawrence G. Thakur Archana
BioDrugs, Vol. 25, Iss. 6, 2011-12 ,pp. :